Chemokine (CCR) and fractalkine (CX3CR) receptors and end stage renal disease

Inflamm Res. 2011 Apr;60(4):399-407. doi: 10.1007/s00011-010-0284-3. Epub 2010 Dec 4.

Abstract

Objective and design: Genetic polymorphisms of chemokines and their receptors were reported to be independent risk factors for inflammation associated disease. We explored the role of CCR5-Δ32, CCR5-G59029A, CX3CR1 V249I and T280M gene polymorphisms as susceptibility for end stage renal disease (ESRD).

Subjects and methods: We genotyped 258 ESRD and 569 healthy controls by sequence-specific primers and RFLP and examined their association.

Results: There was significant difference in genotype frequencies of CCR5-G59029A (p = 0.005), and CX3CR1 V249I (p < 0.0001) between ESRD and controls. No homozygous individuals were observed for CCR5-Δ32. The haplotype analysis of all four studied genes reveled that haplotype +/A/T/I was more significant in patients and associated with higher risk (OR = 2.95) of ESRD. Further, the haplotype of CX3CR1 (T280M, V249I) gene showed 3.6-fold higher in an individual carrying T/I haplotype. No risk was seen for CCR5 haplotypes.

Conclusions: These results highlight the role of CCR5 and CX3CR1 in ESRD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CX3C Chemokine Receptor 1
  • Female
  • Genetic Predisposition to Disease*
  • Genotype
  • Haplotypes
  • Humans
  • Kidney Failure, Chronic / genetics*
  • Kidney Failure, Chronic / immunology*
  • Male
  • Polymorphism, Genetic*
  • Receptors, CCR5 / genetics*
  • Receptors, Cytokine / genetics*
  • Receptors, HIV / genetics*

Substances

  • CX3C Chemokine Receptor 1
  • Receptors, CCR5
  • Receptors, Cytokine
  • Receptors, HIV